Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNPAT | O15228 | 1/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.43 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.38 |
| ▸ | GLP1R | P43220 | 8/20 | 0.37 |
| ▸ | NMT2 | O60551 | 1/20 | 0.36 |
| ▸ | NMT1 | P30419 | 1/20 | 0.36 |
| ▸ | SIRT5 | Q9NXA8 | 2/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20235702 | 0.84 | FOLH1 (0.41) | GNPATFOLH1NOD1GLP1RSIRT5 | |
| SCHEMBL25495167 | 0.83 | GLP1R (0.42) | FOLH1NOD1GLP1REPHX2 | |
| SCHEMBL16231541 | 0.83 | FOLH1 (0.40) | GNPATFOLH1NOD1GLP1RSIRT5 | |
| SCHEMBL24235520 | 0.82 | NOD1 (0.40) | FOLH1NOD1GLP1RNMT2NMT1 | |
| SCHEMBL16231545 | 0.81 | FOLH1 (0.42) | GNPATFOLH1NOD1SIRT5EPHX2 | |
| SCHEMBL16231542 | 0.80 | FOLH1 (0.38) | GNPATFOLH1NOD1GLP1REPHX2 | |
| SCHEMBL25849910 | 0.80 | GLP1R (0.55) | FOLH1NOD1GLP1REPHX2 | |
| SCHEMBL20235730 | 0.80 | FOLH1 (0.44) | GNPATFOLH1NOD1GLP1REPHX2 | |
| SCHEMBL13674388 | 0.78 | GNPAT (0.64) | GNPATFOLH1NOD1GLP1REPHX2 | |
| SCHEMBL21170437 | 0.78 | NOD1 (0.53) | GNPATFOLH1NOD1GLP1REPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023078464-A1 | EPSILON-POLY-L-LYSINE-BASED DRUG CONJUGATE, INTERMEDIATE THEREOF, AND APPLICATION THEREOF | 上海弼领生物技术有限公司 | 2023-05-11 | — | — | WO | disclosed |